Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
You must be a Standard 1 Year member to access this content.
Homburger advised Roche on the offering, and Simpson Thacher & Bartlett advised the initial purchasers. Roche Holdings, Inc. announced it completed its issuance of USD 5.5...
You must be a Standard 1 Year member to access this content.
Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising Roche on the transaction, and Freshfields Bruckhaus Deringer is advising Roivant. Roivant (Nasdaq: ROIV) announced it has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Dechert advised Roche and Foundation Medicine in their partnership. Roche and Foundation Medicine announced their partnership with Gustave Roussy, the leading cancer center in Europe, to...
You must be a Standard 1 Year member to access this content.
Fréget Glaser & Associés assisted the Novartis laboratory in its appeal against the Competition Authority’s decision. The Roche laboratory was advised by Dechert LLP. Novartis has...
You must be a Standard 1 Year member to access this content.
Homburger advised Roche Holding Ltd on the deal. Roche Kapitalmarkt AG issued CHF 800 m Bonds guaranteed by Roche Holding Ltd. Credit Suisse AG and UBS...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Roche on the deal. Hengeler Mueller advised the shareholders of TIB Mobil Group on the transaction. The global pharmaceutical and diagnostics group Roche...
You must be a Standard 1 Year member to access this content.
Homburger advised Roche on the deal, while Simpson Thacher represented the initial purchasers. Roche Holdings, Inc. successfully completed its issuance of USD 500 m 0.450% Notes...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP and DLA Piper LLP advised Roche on the deal. Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics (NASDAQ: GNMK) announced that they have...
You must be a Standard 1 Year member to access this content.
